Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+0.63%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$20.2B
AUM Growth
+$1.24B
(+6.5%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
6.64%
Top 10 Holdings %
Top 10 Hldgs %
12.05%
Holding
3,463
New
955
Increased
736
Reduced
565
Closed
667
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$137M |
| 2 |
Uber
UBER
|
+$130M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$112M |
| 4 |
The Beauty Health Co
SKIN
|
+$107M |
| 5 |
Dynavax Technologies
DVAX
|
+$98.3M |
Top Sells
| 1 |
PARA
Paramount Global Class B
PARA
|
+$181M |
| 2 |
Biogen
BIIB
|
+$181M |
| 3 |
Danaher
DHR
|
+$108M |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$103M |
| 5 |
Aon
AON
|
+$100M |
Sector Composition
| 1 | Healthcare | 24.21% |
| 2 | Financials | 19.75% |
| 3 | Technology | 16.44% |
| 4 | Consumer Discretionary | 13.14% |
| 5 | Industrials | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OYST
2026
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $331K | ﹤0.01% |
+27,946
| New | +$331K |
|
2027
Limoneira
LMNR
$275M
| $330K | ﹤0.01% |
20,398
-20,230
| -50% | -$327K |
|
2028
Franco-Nevada
FNV
$38.6B
| $329K | ﹤0.01% |
+2,528
| New | +$329K |
|
2029
CareDx
CDNA
$720M
| $328K | ﹤0.01% |
5,173
+2,377
| +85% | +$151K |
|
2030
First Citizens BancShares
FCNCA
$25.5B
| $328K | ﹤0.01% |
+389
| New | +$328K |
|
2031
Verisk Analytics
VRSK
$36.6B
| $328K | ﹤0.01% |
1,636
-21,421
| -93% | -$4.29M |
|
|
LFG
2032
DELISTED
Archaea Energy Inc.
LFG
| $328K | ﹤0.01% |
+17,330
| New | +$328K |
|
|
PHX
2033
DELISTED
PHX Minerals
PHX
| $327K | ﹤0.01% |
106,751
+36,430
| +52% | +$112K |
|
2034
Schwab US Large-Cap Value ETF
SCHV
$13.5B
| $327K | ﹤0.01% |
+14,559
| New | +$327K |
|
|
MRLN
2035
DELISTED
Marlin Business Services Corp
MRLN
| $327K | ﹤0.01% |
14,707
+3,951
| +37% | +$87.8K |
|
|
TREC
2036
DELISTED
Trecora Resources
TREC
| $326K | ﹤0.01% |
+39,848
| New | +$326K |
|
2037
ASML
ASML
$320B
| $325K | ﹤0.01% |
+436
| New | +$325K |
|
2038
First Mid Bancshares
FMBH
$945M
| $325K | ﹤0.01% |
+7,914
| New | +$325K |
|
2039
ArcBest
ARCB
$1.6B
| $323K | ﹤0.01% |
+3,945
| New | +$323K |
|
2040
LKQ Corp
LKQ
$8.31B
| $322K | ﹤0.01% |
+6,393
| New | +$322K |
|
2041
AllianceBernstein
AB
$4.19B
| $321K | ﹤0.01% |
+6,483
| New | +$321K |
|
2042
Clearside Biomedical
CLSD
$25.1M
| $321K | ﹤0.01% |
53,474
-176,967
| -77% | -$1.06M |
|
|
BCYC
2043
Bicycle Therapeutics
BCYC
$490M
| $320K | ﹤0.01% |
7,694
| – | – |
|
|
CSR
2044
Centerspace
CSR
$979M
| $320K | ﹤0.01% |
+3,387
| New | +$320K |
|
2045
Latham Group
SWIM
$916M
| $320K | ﹤0.01% |
19,514
+824
| +4% | +$13.5K |
|
2046
Intrepid Potash
IPI
$389M
| $317K | ﹤0.01% |
+10,257
| New | +$317K |
|
2047
Sally Beauty Holdings
SBH
$1.48B
| $315K | ﹤0.01% |
+18,673
| New | +$315K |
|
2048
Definitive Healthcare
DH
$432M
| $314K | ﹤0.01% |
+7,333
| New | +$314K |
|
2049
Oriental Culture Holding
OCG
$83.4M
| $313K | ﹤0.01% |
+15,895
| New | +$313K |
|
2050
CoreCard
CCRD
$211M
| $312K | ﹤0.01% |
+7,677
| New | +$312K |
|